Selvita provides its clients with effective drug discovery support based on broad capabilities and deep experience in small molecule drug discovery, starting from target validation up to the selection of a clinical candidate. We powerfully execute fully-integrated drug discovery programs combining all of Selvita’s core skills in biology and chemistry or else provide partially-integrated or stand-alone services utilising selected capabilities optimally matched to the specific needs of our clients.
Our goal is to provide efficacious, safe, and differentiated preclinical candidates.
We place a strong emphasis on translational science, focusing on disease-relevant animal models and ex-vivo studies where appropriate from patient samples, with the discovery process driven by expert medicinal chemistry and ADME/PK. Inflammation, infection and oncology are our core expertise, accompanied by experience in additional therapeutic areas.
